NCT01827475

Brief Summary

The purpose of this study is to determine whether the combination of ibuprofen and acetaminophen, is more effective than either single agent alone in treating pain from acute musculoskeletal injuries in the emergency department.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_2 pain

Timeline
Completed

Started Jul 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

April 4, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 9, 2013

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

December 31, 2014

Completed
Last Updated

December 31, 2014

Status Verified

December 1, 2014

Enrollment Period

1 year

First QC Date

April 4, 2013

Results QC Date

April 9, 2013

Last Update Submit

December 29, 2014

Conditions

Keywords

musculoskeletal painacetaminophenibuprofen

Outcome Measures

Primary Outcomes (1)

  • Pain Severity

    Pain score on 100 mm VAS from 0 (no pain) to 100 (worst pain)

    1 hour

Secondary Outcomes (1)

  • Need for Rescue Pain Relief

    1 hour

Study Arms (3)

Ibuprofen

ACTIVE COMPARATOR

Ibuprofen 800 mg

Drug: Ibuprofen

Acetaminophen

ACTIVE COMPARATOR

Acetaminophen 1 gm

Drug: Acetaminophen

Ibuprofen-acetaminophen combination

EXPERIMENTAL

Ibuprofen 800 mg plus acetaminophen 1 gm

Drug: Ibuprofen-acetaminophen combination

Interventions

single dose

Also known as: motrin
Ibuprofen

single dose

Also known as: tylenol
Acetaminophen

single dose

Also known as: motrin, tylenol
Ibuprofen-acetaminophen combination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients who presented to the emergency department with pain (a verbal numeric pain score greater than 0 on a scale of 0 to 10 from none to greatest) secondary to an acute musculoskeletal injury of less than 24 hours of duration when one of the study investigators was present were eligible for enrollment

You may not qualify if:

  • Patients who had taken an opioid containing analgesic as well as those with a prior history of allergy or contraindications to ibuprofen or acetaminophen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Jones P, Lamdin R, Dalziel SR. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database Syst Rev. 2020 Aug 12;8(8):CD007789. doi: 10.1002/14651858.CD007789.pub3.

MeSH Terms

Conditions

PainMusculoskeletal Pain

Interventions

IbuprofenAcetaminophen

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Limitations and Caveats

Small sample size, single center, short follow up

Results Point of Contact

Title
Dr. Adam Singer
Organization
Emergency Medicine, Stony Brook U

Study Officials

  • Adam J Singer, MD

    Stony Brook University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Vice Chair

Study Record Dates

First Submitted

April 4, 2013

First Posted

April 9, 2013

Study Start

July 1, 2010

Primary Completion

July 1, 2011

Study Completion

July 1, 2011

Last Updated

December 31, 2014

Results First Posted

December 31, 2014

Record last verified: 2014-12